Carmignac Gestion’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-75,625
Closed -$3.26M 132
2019
Q1
$3.26M Sell
75,625
-198,834
-72% -$8M 0.04% 87
2018
Q4
$10M Sell
274,459
-1,082,617
-80% -$40.2M 0.15% 55
2018
Q3
$54.5M Sell
1,357,076
-900,817
-40% -$36M 0.46% 43
2018
Q2
$86.6M Buy
2,257,893
+636,506
+39% +$23.4M 0.65% 43
2018
Q1
$55.5M Buy
1,621,387
+280,822
+21% +$9.86M 0.39% 47
2017
Q4
$44M Buy
+1,340,565
New +$46.2M 0.29% 45

Other funds holding QGEN

Carmignac Gestion's QGEN Position: Q2 2019 in Review

Carmignac Gestion sold out of Qiagen (QGEN) in Q2 2019, closing a stake of 75,625 shares — an estimated $3.26M sold.

Carmignac Gestion first reported a position in QGEN in Q4 2017 and held it in 6 quarters. The position peaked at $86.6M in Q2 2018. 262 funds tracked by Wall St. Rank hold QGEN as of Q2 2019.

  • Carmignac Gestion reported no remaining Qiagen position as of Q2 2019 after selling out during the quarter.
  • Carmignac Gestion sold 75,625 Qiagen shares in Q2 2019, an estimated $3.26M.
  • Carmignac Gestion first reported a position in Qiagen in Q4 2017 and held it in 6 quarters.
  • Carmignac Gestion's Qiagen position peaked at $86.6M in Q2 2018.
  • 262 funds tracked by Wall St. Rank held Qiagen as of Q2 2019.

Based on Carmignac Gestion's 13F filing for Q2 2019, filed 13 Aug 2019.